Received Mar 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y015558 | OT |
No other AE/PQC reported.; patient was administered less than a full dose of VARIVAX.; This spontaneous report was received from a Nurse and refers to a(n) 12-month-old male patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 07-Mar-2025, the patient started therapy with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), (lot #Y015558, expiration date: 16-Sep-2026) administered by unknown route as prophylaxis. The patient started therapy with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX REFRIGERATOR STABLE), for the treatment of prophylaxis together with sterile diluent (MERCK STERILE DILUENT) (lot#, expiration date, route of administration were all not provided). On the same date, the patient experienced administered less than a full dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) (vaccine underdose). There were no other adverse events reported (no adverse event). Reporter stated he did not know how much of the dose the patient received.
Sterile diluent